Caracterización de pacientes hospitalizados con infarto agudo de miocardio en la Clínica Shaio de 2018 a 2022 (REMISHAIO)
| dc.contributor.advisor | Gómez López, Efraín Alfonso | |
| dc.contributor.author | Gómez Valencia , Aura María | |
| dc.contributor.other | Gilón Cordoba, Laura Fernanda | |
| dc.contributor.other | Mendoza Beltrán, Fernán del Cristo | |
| dc.contributor.other | Jaramillo Villegas, Claudia | |
| dc.contributor.other | Poveda Henao, Claudia Marcela | |
| dc.date.accessioned | 2025-02-13T22:16:48Z | |
| dc.date.available | 2025-02-13T22:16:48Z | |
| dc.date.issued | 2025-01 | |
| dc.description.abstract | Introducción La enfermedad coronaria es una enfermedad con alta prevalencia, genera alto costo al sistema de salud con pérdida de años laborales ajustados a discapacidad. Es la principal causa de muerte en todo el mundo. Existen diferencias geográficas en factores de riesgo, presentación clínica, tratamiento farmacológico, estrategias de reperfusión y pronostico. Son escasos los datos publicados en Colombia de infarto agudo de miocardio. Objetivo Caracterizar la población adulta con infarto agudo de miocardio de la cohorte REMISHAIO de pacientes hospitalizados de Marzo 2018 a Marzo de 2022 en la unidad coronaria de Fundación Clínica Shaio de Bogotá Metodología Se realizó un estudio de cohorte retrospectivo con la descripción de las características clínicas y demográficas de la población, el tratamiento farmacológico e intervencionista realizadas y las complicaciones presentadas durante la hospitalización. Resultados Se incluyeron 1656 pacientes con infarto agudo de miocardio. La mediana de edad fue 66 años (RIQ 58-75), con predominio del sexo masculino con 67.5%. El infarto agudo de miocardio sin elevación del ST fue más frecuente con 66% y el infarto con elevación del ST fue 34%. Los factores de riesgo más comunes fueron hipertensión arterial 55.3%, tabaquismo 30.9%, dislipidemia 22.7%, diabetes mellitus 20.8%, enfermedad coronaria previa 14.4%. la mediana de fracción de eyección del ventrículo izquierdo fue 52% (RIQ 41-60). En infarto con elevación del ST fue más frecuente la localización inferior 37.4%, seguida por anterior 36.2%. La antiagregación más utilizada fue aspirina con clopidogrel. Se realizo cateterismo cardiaco al 93.5% de pacientes con infarto agudo de miocardio y angioplastia al 64.7%. La complicación cardiovascular más común fue choque cardiogénico en 6.9% y la mortalidad hospitalaria fue del 3.2%. Conclusiones Se encontró similitudes en cuanto a factores de riesgo de IAM. Se destaca mayor porcentaje de pacientes con IAMST que reciben reperfusión percutánea, adecuada adherencia a las guías de práctica clínica en cuanto a la prescripción del manejo farmacológico y menor incidencia de complicaciones como falla cardiaca, mortalidad y arritmias ventriculares. | |
| dc.description.abstractenglish | Introduction Coronary artery disease is a highly prevalent disease that generates high costs to the health system with loss of disability-adjusted work years. It is the leading cause of death worldwide. There are geographic differences in risk factors, clinical presentation, pharmacological treatment, reperfusion strategies, and prognosis. There are few published data in Colombia on acute myocardial infarction. Objective To characterize the adult population with acute myocardial infarction in the REMISHAIO cohort of patients hospitalized from March 2018 to March 2022 in the coronary unit of the Fundación Clínica Shaio in Bogotá. Methodology A retrospective cohort study was conducted with the description of the clinical and demographic characteristics of the population, the pharmacological and interventional treatment performed, and the complications presented during hospitalization. Results 1,656 patients with acute myocardial infarction were included. The median age was 66 years (IQR 58-75), with a male predominance at 67.5%. Non-ST-segment elevation myocardial infarction was more frequent at 66% and ST-segment elevation myocardial infarction was 34%. The most common risk factors were arterial hypertension 55.3%, smoking 30.9%, dyslipidemia 22.7%, diabetes mellitus 20.8%, and previous coronary disease 14.4%. The median left ventricular ejection fraction was 52% (IQR 41-60). In ST-segment elevation myocardial infarction, the most frequent location was inferior 37.4%, followed by anterior 36.2%. The most commonly used antiplatelet agent was aspirin with clopidogrel. Cardiac catheterization was performed in 93.5% of patients with acute myocardial infarction and angioplasty in 64.7%. The most common cardiovascular complication was cardiogenic shock in 6.9% and in-hospital mortality was 3.2%. Conclusions Similarities were found in terms of risk factors for AMI. There was a higher percentage of patients with STEMI who received percutaneous reperfusion, adequate adherence to clinical practice guidelines regarding the prescription of pharmacological management and a lower incidence of complications such as heart failure, mortality and ventricular arrhythmias. | |
| dc.description.degreelevel | Especialización | spa |
| dc.description.degreename | Especialista en Cardiología de Adultos | spa |
| dc.description.sponsorship | Fundación Clinica Shaio | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.instname | instname:Universidad El Bosque | spa |
| dc.identifier.reponame | reponame:Repositorio Institucional Universidad El Bosque | spa |
| dc.identifier.repourl | repourl:https://repositorio.unbosque.edu.co | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12495/13954 | |
| dc.language.iso | es | |
| dc.publisher.faculty | Facultad de Medicina | spa |
| dc.publisher.grantor | Universidad El Bosque | spa |
| dc.publisher.program | Especialización en Cardiología Adultos | spa |
| dc.relation.references | 1. Nohria R, Viera AJ. Acute Coronary Syndrome: Diagnosis and Initial Management [Internet]. Vol. 109, American Family Physician www.aafp.org/afp. 2024. | |
| dc.relation.references | 2. Yuan D, Chu J, Qian J, Lin H, Zhu G, Chen F, et al. New Concepts on the Pathophysiology of Acute Coronary Syndrome. Vol. 24, Reviews in Cardiovascular Medicine. IMR Press Limited; 2023. | |
| dc.relation.references | 3. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America: The INTERHEART Latin American study. Circulation. 2007 Mar;115(9):1067–74. | |
| dc.relation.references | 4. Yusuf PS, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004 Sep 11;364(9438):937–52. | |
| dc.relation.references | 5. Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, et al. CARMELA: Assessment of Cardiovascular Risk in Seven Latin American Cities. American Journal of Medicine. 2008 Jan;121(1):58–65. | |
| dc.relation.references | 6. Thygesen K, Alpert J. Consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio. Revista Española de Cardioogia. 2019;72(1):e1–27. | |
| dc.relation.references | 7. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes Supplementary data. Eur Heart J. 2023 Oct 7;0(0):1–52. | |
| dc.relation.references | 8. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 7;44(38):3720–826. | |
| dc.relation.references | 9. Fanaroff AC, Rymer JA, Goldstein SA, Simel DL, Newby LK. Does this patient with chest pain have acute coronary syndrome?: The rational clinical examination systematic review. Vol. 314, JAMA - Journal of the American Medical Association. American Medical Association; 2015. p. 1955–65. | |
| dc.relation.references | 10. Fernández-De-Bobadilla J, López-De-Sá E. Economic and Social Burden of Coronary Heart Disease EPIDEMIOLOGÍA Y CARGA DE ENFERMEDAD DE LA ENFERMEDAD CORONARIA. Vol. 13, Rev Esp Cardiol Supl. 2013. | |
| dc.relation.references | 11. Bahit MC, Kochar A, Granger CB. Post-Myocardial Infarction Heart Failure. Vol. 6, JACC: Heart Failure. Elsevier Inc.; 2018. p. 179–86. | |
| dc.relation.references | 12. Udith J, Ochman SH, Leeper YAS, Ohn J, Ebb GW, Anborn IAS, et al. EARLY REVASCULARIZATION IN ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK A BSTRACT Background The leading cause of death in pa. Vol. 341. 1999. | |
| dc.relation.references | 13. McCarthy CP, Raber I, Chapman AR, Sandoval Y, Apple FS, Mills NL, et al. Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians. JAMA Cardiol. 2019 Oct 1;4(10):1034–42. | |
| dc.relation.references | 14. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 7;44(38):3720–826. | |
| dc.relation.references | 15. Manzano-Fernández S, Sánchez-Martínez M, Flores-Blanco PJ, López-Cuenca Á, Gómez-Molina M, Pastor-Pérez FJ, et al. Comparison of the global registry of acute coronary events risk score versus the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines risk score to predict in-hospital mortality and major bleeding in acute coronary syndromes. American Journal of Cardiology. 2016 Apr 1;117(7):1047–54. | |
| dc.relation.references | 16. Keeley E, Boura J. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction- a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20. | |
| dc.relation.references | 17. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine [Internet]. 2007 Nov 15;357(20):2001–15. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa0706482 | |
| dc.relation.references | 18. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 2009 Sep 10;361(11):1045–57. | |
| dc.relation.references | 19. Chavarriaga JC, Beltrán J, Senior JM. Características epidemiológicas, clínicas, tratamiento y pronóstico de los pacientes con diagnóstico de síndrome coronario agudo en unidad especializada. Acta Medica Colombiana [Internet]. 2014;39(1):21–8. Available from: http://www.timi.org/ | |
| dc.relation.references | 20. Martinez-Sanchez C, Borrayo G, Carrillo J, Juarez U, Quintanilla J, Jerjes-Sanchez C. Abordaje clínico y evolución hospitalaria en pacientes mexicanos con sindrome coronario agudo: El Tercer Registro Nacional de Síndromes Coronarios Agudos (RENASICA III). Arch Cardiol Mex. 2016 Jul 1;86(3):221–32. | |
| dc.relation.references | 21. Ahuja KR, Saad AM, Nazir S, Ariss RW, Shekhar S, Isogai T, et al. Trends in Clinical Characteristics and Outcomes in ST-Elevation Myocardial Infarction Hospitalizations in the United States, 2002-2016. Curr Probl Cardiol. 2022 Dec 1;47(12). | |
| dc.relation.references | 22. Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, et al. Acute myocardial infarction: Changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015. Circulation. 2017;136(20):1908–19. | |
| dc.relation.references | 23. Filgueiras Filho NM, Feitosa Filho GS, Solla DJF, Argôlo FC, Guimarães PO, Paiva Filho I de M, et al. Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador’s STEMI Registry (RESISST). J Am Heart Assoc. 2018 Jul 6;7(14). | |
| dc.relation.references | 24. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002 Aug;23(15):1190–201. | |
| dc.relation.references | 25. Padinhare Mohanan, Rony Mathew. Presentation, management, and outcomesof 25 748 acute coronary syndrome admissionsin Kerala, India: results from the KeralaACS Registry. Vol. 34, European Heart Journal. 2013. p. 121–9. | |
| dc.relation.references | 26. Gabriel Steg P, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline Characteristics, Management Practices, and In-Hospital Outcomes of Patients Hospitalized With Acute Coronary Syndromes in the Global Registry of Acute Coronary Events (GRACE)* [Internet]. Available from: www.outcomes.org/grace. | |
| dc.relation.references | 27. NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4. Vol. 396, The Lancet. Lancet Publishing Group; 2020. p. 918–34. | |
| dc.relation.references | 28. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. Vol. 80, Journal of the American College of Cardiology. Elsevier Inc.; 2022. p. 2361–71. | |
| dc.relation.references | 29. González G, Fernández F, Ávalos D, Ortellado J, Adorno M, Galeano J, et al. National Registry of Acute Coronary Syndrome in Paraguay (RENASCA-PY). Arch Cardiol Mex. 2022 Apr 1;92(2):174–80. | |
| dc.relation.references | 30. Akter F, Masood N, Shakil Malik S, Mubarik S, Wang Y. Prediction of cardiovascular diseases mortality- and disability-adjusted life-years attributed to modifiable dietary risk factors from 1990 to 2030 among East Asian countries and the world [Internet]. Available from: http://ghdx.healthdata.org/gbd-results-tool | |
| dc.relation.references | 31. Las 10 principales causas de defunción. WHO. [Internet]. [cited 2024 Mar 28]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death | |
| dc.relation.references | 32. Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries. New England Journal of Medicine. 2014 Aug 28;371(9):818–27. | |
| dc.relation.references | 33. Sicras-Mainar A, Fernández De Bobadilla J, Navarro-Artieda R, Martín I, Varela-Moreno C. Morbimortalidad y consumo de recursos asociados tras síndrome coronario agudo en una población española. Rev Clin Esp. 2011 Dec;211(11):560–71. | |
| dc.relation.references | 34. DANE. Estadísticas Vitales. Cifras de defunciones. Diciembre 2023. Gov.co. [Internet]. [cited 2024 Mar 28]. Available from: https://www.dane.gov.co/files/operaciones/EEVV/pres-EEVV-Defunciones-IIItrim2023.pdf | |
| dc.relation.references | 35. Gridnev VI, Kiselev AR, Posnenkova OM, Popova Y V., Dmitriev VA, Prokhorov MD, et al. Objectives and Design of the Russian Acute Coronary Syndrome Registry (RusACSR). Clin Cardiol. 2016 Jan 1;39(1):1–8. | |
| dc.relation.references | 36. O’Brien E. How Registries Can Guide Our Future? Vol. 69, Hypertension. Lippincott Williams and Wilkins; 2017. p. 198–9. | |
| dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International | en |
| dc.rights.accessrights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.local | Acceso abierto | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | Infarto de miocardio | |
| dc.subject | Reperfusion | |
| dc.subject | Unidad Coronaria | |
| dc.subject.keywords | Myocardial Infarction | |
| dc.subject.keywords | Reperfusions | |
| dc.subject.keywords | Coronary Unit | |
| dc.subject.nlm | WG 100 | |
| dc.title | Caracterización de pacientes hospitalizados con infarto agudo de miocardio en la Clínica Shaio de 2018 a 2022 (REMISHAIO) | |
| dc.title.translated | Characterization of patients hospitalized with acute myocardial infarction at the Shaio Clinic from 2018 to 2022 (REMISHAIO) | |
| dc.type.coar | https://purl.org/coar/resource_type/c_7a1f | |
| dc.type.coarversion | https://purl.org/coar/version/c_ab4af688f83e57aa | |
| dc.type.driver | info:eu-repo/semantics/bachelorThesis | |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | |
| dc.type.local | Tesis/Trabajo de grado - Monografía - Especialización | spa |